reports
Tecnotree Oyj: 1 director
A director at Tecnotree Oyj sold 10,937 shares at 5.394EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Nigbas Nigde Beton Sanayi Ve: 1 director
A director at Nigbas Nigde Beton Sanayi Ve sold 1,620,000 shares at 21.055TRY and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Aqua Metals Joins $4.99 Million DOE Grant Project to Pioneer Domestic ...
Aqua Metals Joins $4.99 Million DOE Grant Project to Pioneer Domestic Critical Mineral Supply Chain RENO, Nev., May 10, 2024 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling technology, is proud to announce its collaboration in a significant U.S. Department of Energy (DOE) grant project. As part of a consortium led by Pennsylvania State University, Aqua Metals will play a crucial role in the $4.99 million initiative aimed at establishing a fully domestic supply chain for critical minerals essential for modern technologies, from e...
Eezy Plc - Managers' Transactions – Siina Saksi
Eezy Plc - Managers' Transactions – Siina Saksi EEZY PLC -- MANAGERS TRANSACTIONS -- 10 MAY 2024 AT 15:10 Eezy Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Siina SaksiPosition: Chief Executive OfficerIssuer: Eezy OyjLEI: 743700ZKOMTB7X00OW54Notification type: INITIAL NOTIFICATIONReference number: 62380/5/4____________________________________________Transaction date: 2024-05-10Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000322326Nature of transaction: ACQUISITION Transaction details(1):...
Eezy Oyj - Johdon liiketoimet - Siina Saksi
Eezy Oyj - Johdon liiketoimet - Siina Saksi EEZY OYJ -- JOHDON LIIKETOIMET -- 10.5.2024 klo 15:10 Eezy Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Siina SaksiAsema: ToimitusjohtajaLiikkeeseenlaskija: Eezy OyjLEI: 743700ZKOMTB7X00OW54Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 62380/5/4____________________________________________Liiketoimen päivämäärä: 2024-05-10Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI4000322326Liiketoimen luonne: HANKINTA Liiketoimien yksityiskohtaiset tiedot(1): Volyymi: 10 Y...
Alliance Trust PLC - Net Asset Value
Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC At the close of business Thursday 09 May 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was - excluding income, 1277.8p - including income, 1284.7p The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was - excluding income, 1282.0p - including income, 1288.9p For further information, please contact: - Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated in a...
Telos Corporation Announces First Quarter Results Above Guidance: Repo...
Telos Corporation Announces First Quarter Results Above Guidance: Reports $29.6 Million of Revenue, 37.0% GAAP Gross Margin, and 42.2% Cash Gross Margin Reports First Quarter Results Above High End of Guidance Range on Key Financial MetricsDelivered $29.6 Million of Revenue, Reflecting Outperformance by Security SolutionsGenerated 37.0% GAAP Gross Margin; Expanded Cash Gross Margin by 249 Basis Points to 42.2%Cash Flow From Operations Was a Modest $0.4 Million Outflow; Free Cash Flow Improved Year-Over-YearRevenues Expected to Return to Sequential Growth in the Third or Fourth Quarter of 20...
Aekyung Chemical: 1 director
A director at Aekyung Chemical sold 2,100 shares at 14,000.000KRW and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Healthcare Co Ltd: 1 director
A director at Healthcare Co Ltd bought 1,257,100 shares at 8.510CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Eezy Plc - Manager's Transactions - DG Holding Oy
Eezy Plc - Manager's Transactions - DG Holding Oy EEZY PLC -- MANAGERS TRANSACTIONS -- 10 MAY 2024 AT 15:00 Eezy Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: DG Holding OyPosition: Member of the Board/Deputy member(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Markus JussilaPosition: Other senior managerIssuer: Eezy OyjLEI: 743700ZKOMTB7X00OW54Notification type: INITIAL NOTIFICATIONReference number: 62245/10/10____________________________________________Transaction da...
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and...
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced financial results for the first quarter ended March 31, 2024, and provided a corporate update. “Ocuphire has made significant progress in 2024, with important developments for both APX3330 and RYZUMVI™,” said Ge...
Doman Building Materials Group Ltd. Announces Meeting Results for Elec...
Doman Building Materials Group Ltd. Announces Meeting Results for Election of Directors THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, May 10, 2024 (GLOBE NEWSWIRE) -- Doman Building Materials Group Ltd. (“Doman”) or the “Company”) (TSX:DBM) announced its director election results following its annual and special meeting of shareholders, held May 9, 2024. All of the nominees proposed as directors in the Company's Management Informatio...
Eezy Oyj - Johdon liiketoimet - DG Holding Oy
Eezy Oyj - Johdon liiketoimet - DG Holding Oy EEZY OYJ -- JOHDON LIIKETOIMET -- 10.5.2024 klo 15:00 Eezy Oyj - Johdon liiketoimet ____________________________________________IlmoitusvelvollinenNimi: DG Holding OyAsema: Hallituksen jäsen/varajäsen(X) Oikeushenkilö (1):Liikkeeseenlaskijassa johtotehtävissä toimiva henkilöNimi: Markus JussilaAsema: Muu ylin johtoLiikkeeseenlaskija: Eezy OyjLEI: 743700ZKOMTB7X00OW54Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 62245/10/10____________________________________________Liiketoimen päivämäärä: 2024-05-08Kauppapaikka: NASDAQ HELSINK...
Dycom Industries, Inc. to Host Fiscal 2025 First Quarter Results Confe...
Dycom Industries, Inc. to Host Fiscal 2025 First Quarter Results Conference Call PALM BEACH GARDENS, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2025 first quarter results on Wednesday, May 22, 2024, at 9:00 a.m. Eastern time. Dycom will issue a press release reporting its results earlier that morning. Interested parties may participate in the question and answer session of the conference call by registering at . Upon registration, participants will receive a dial-in number and unique PIN to access the call. Parti...
Praxis Precision Medicines to Report First Quarter 2024 Financial Resu...
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024 BOSTON, May 10, 2024 (GLOBE NEWSWIRE) -- , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will report financial results for the first quarter 2024 on Monday, May 13, 2024, before the U.S. financial markets open. About Praxis Praxis Precision Medicines is a clinical-stage biopharmaceutical...
Mobile-health Network Solutions Expands Services to Malaysia
Mobile-health Network Solutions Expands Services to Malaysia SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced the establishment of a subsidiary in Malaysia. This strategic expansion signifies MNDR's commitment to delivering accessible and affordable healthcare services throughout Southeast Asia. Solidifying Regional Leadership The Malaysian subsidiary marks a pivotal step in the Company’s growth trajectory. It positions the Company as a fro...
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Dev...
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features that may further augment the therapeutic potential of MSCs in treating inflammatory diseases by precluding batch-to-batch inconsistencies, promoting in viv...
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Dr...
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the Ekso Indego Personal will be featured on ‘Health Uncensored’ hosted by Dr. Drew Pinsky. The episode is scheduled to air on the Fox Business News channel on Sunday, May 12 at 5:30 p.m. ET / 2:30 p.m. PT. Scott Dav...
Liquidia Announces Poster Presentation at the American Thoracic Societ...
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD MORRISVILLE, N.C., May 10, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data related to the investigational use of L606 (liposomal treprostinil) inhalation suspension in people with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) at the American Thoracic Society (AT...
Smart for Life to Attend Vitafoods Europe 2024: Positioned to Identify...
Smart for Life to Attend Vitafoods Europe 2024: Positioned to Identify Strategic Partnerships and Potential Acquisitions Renowned Industry Leader and Smart for Life Board Member Heather Granato to Speak at Nutraceutical Event in Geneva, Switzerland MIAMI, May 10, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced its participation in Vitafoods Europe 2024, scheduled to take place in Gen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.